Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY

Filed by JEFFREY J. KIMBELL & ASSOCIATES, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-21 06:26:11 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
9e8939c5-1bbe-4b6d-b522-6404b2ccaf0f
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience; Issues related to tariffs; Issues related to 503B Compounding.

PHA · Pharmacy

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience; Issues related tariffs; Issues related to 503B Compounding

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.